Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: Comparison with C-reactive protein

Cytokine

Volumn 53, Issue 3, 2011, Pages 342-346

  Nishida, Hidenori ^a   Horio, Takeshi ^a   Suzuki, Yoshihiko ^b   Iwashima, Yoshio ^a   Tokudome, Takeshi ^a   Yoshihara, Fumiki ^a   Nakamura, Satoko ^a   Kawano, Yuhei ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

C reactive protein; Cardiovascular disease; Interleukin 6; Morbidity

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; FEMALE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TRANSIENT ISCHEMIC ATTACK;

AGED; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; JAPAN; KAPLAN-MEIER ESTIMATE; LIPIDS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 79251645456     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.12.005     Document Type: Article

References (34)

1. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998, 128:127-137.
2. Xin X., Cai Y., Matsumoto K., Agui T. Endothelin-induced interleukin-6 production by rat aortic endothelial cells. Endocrinology 1995, 136:132-137.
3. Loppnow H., Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest 1990, 85:731-738.
4. Biasucci L.M., Liuzzo G., Fantuzzi G., Caligiuri G., Rebuzzi A.G., Ginnetti F., et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999, 99:2079-2084.
5. Ikonomidis I., Andreotti F., Economou E., Stefanadis C., Toutouzas P., Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999, 100:793-798.
6. Erren M., Reinecke H., Junker R., Fobker M., Schulte H., Schurek J.O., et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999, 19:2355-2363.
7. Tsutamoto T., Hisanaga T., Wada A., Maeda K., Ohnishi M., Fukai D., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998, 31:391-398.
8. Dibbs Z., Thornby J., White B.G., Mann D.L. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 1999, 33:1935-1942.
9. Juvonen J., Surcel H.M., Satta J., Teppo A.M., Bloigu A., Syrjälä H., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997, 17:2843-2847.
10. Uno H., Ueki Y., Murashima J., Miyake S., Tominaga Y., Eguchi K., et al. Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerosis obliterans. Atherosclerosis 1995, 116:93-102.
11. Yoshida M., Tomitori H., Machi Y., Katagiri D., Ueda S., Horiguchi K., et al. Acrolein, IL-6 and CRP as markers of silent brain infarction. Atherosclerosis 2009, 203:557-562.
12. Amar J., Fauvel J., Drouet L., Ruidavets J.B., Perret B., Chamontin B., et al. Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1. J Hypertens 2006, 24:1083-1088.
13. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., Fowkes F.G. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005, 112:976-983.
14. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
15. Luc G., Bard J.M., Juhan-Vague I., Ferrieres J., Evans A., Amouyel P., et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol 2003, 23:1255-1261.
16. Fisman E.Z., Benderly M., Esper R.J., Behar S., Boyko V., Adler Y., et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 2006, 98:14-18.
17. Welsh P., Lowe G.D., Chalmers J., Campbell D.J., Rumley A., Neal B.C., et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 2008, 39:2226-2230.
18. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
19. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
20. Koenig W., Sund M., Fröhlich M., Fischer H.G., Löwel H., Döring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999, 99:237-242.
21. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
22. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino R.B., Wilson P.W.F. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004, 110:380-385.
23. Suzuki Y., Horio T., Hayashi T., Nonogi H., Kitamura K., Eto T., et al. Plasma adrenomedullin concentration is increased in patients with peripheral arterial occlusive disease associated with vascular inflammation. Regul Pept 2004, 118:99-104.
24. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
25. Horio T., Iwashima Y., Kamide K., Tokudome T., Yoshihara F., Nakamura S., et al. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J Hypertens 2010, 28:1738-1744.
26. van der Meer I.M., de Maat M.P., Kiliaan A.J., van der Kuip D.A., Hofman A., Witteman J.C. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med 2003, 163:1323-1328.
27. Wilson P.W., Nam B.H., Pencina M., D'Agostino R.B., Benjamin E.J., O'Donnell C.J. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med 2005, 165:2473-2478.
28. Matsushita K., Yatsuya H., Tamakoshi K., Yang P.O., Otsuka R., Wada K., et al. High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk. Circ J 2007, 71:820-825.
29. Seino Y., Ikeda U., Ikeda M., Yamamoto K., Misawa Y., Hasegawa T., et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994, 6:87-91.
30. Rus H.G., Vlaicu R., Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996, 127:263-271.
31. Yan S.F., Tritto I., Pinsky D., Liao H., Huang J., Fuller G., et al. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 1995, 270:11463-11471.
32. Baba T., Uchimura I., Fujisawa K., Morohoshi M., Asaoka H., Tanaka A., et al. Production of interleukin-6 induced by hypoxia linked to peripheral arterial disease. Ann NY Acad Sci 1997, 811:542-548.
33. Raymond R.J., Dehmer G.J., Theoharides T.C., Deliargyris E.N. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 2001, 141:435-438.
34. Dinh W., Füth R., Nickl W., Krahn T., Ellinghaus P., Scheffold T., et al. Cardiovasc Diabetol 2009, 8:58.